The complex three-way love triangle between Mylan Pharmaceuticals Inc. (NASDAQ:MYL), Teva Pharmaceutical Industries (NYSE:TEVA) and Perrigo Company PLC. (NYSE:PRGO) intensified this week, as Israel’s Teva made an unsolicited $40 billion offer for Mylan in what would be the tenth largest pharmaceutical in the history. The hostile takeover bid, aimed at strengthening up Teva’s generic drugs business, comes just weeks after Mylan announced it was attempting to buy Perrigo for approximately $30 billion..
Predicting movement in Financial Markets is tough, try Ruble
Russia’s currency, the Ruble, went from the world’s worst to the best performer in the first three months of 2015. It has most certainly caught even the most avid forecasters off guard. […]The Russian currency strengthened on Thursday, April 16, 2015, bolstered by a recent rally which had been driven by greater confidence in the ruble, easing international tensions over Ukraine and oil price stability.